StockGuru Spotlights October 4, 2011: GNBP Up 14% In Less Than Two Weeks – $86.98M Market Cap

StockGuru Spotlights October 4, 2011:  GNBP Up 14% In Less Than Two Weeks – $86.98M Market Cap

StockGuru Spotlights

October 4, 2011


Dear Members:

These Spotlights have made tremendous moves. As you can see, StockGuru brings you the very stocks you want on your radar, in your portfolio and to trade.

StockGuru Spotlight Spotlight Price Symbol High Up As Much As Market Cap
June 30, 2011 $0.04 EPAZ $0.07 75% $2.31M
August 12, 2011 $0.25 MGLT $0.40 60% $9.69M
August 23, 2011 $2.25 CCLR $3.25 44% $7.87M
July 7, 2011 $0.25 EWVE $0.47 88% $5.77M
August 23, 2011 $0.20 ACCM $0.25 25% $8.21M
September 20, 2011 $0.98 GNBP $1.12 14% $86.98M

Genesis Biopharma, Inc. (OTCBB:GNBP), a biotechnology company developing targeted cancer immunotherapies, announced on September 19, 2011, the engagement of four senior industry consultants. “These senior consultants will form a dynamic team to help drive the clinical and commercial progress of Contego(TM), our autologous cell therapy for the treatment of Stage IV metastatic melanoma,” said Anthony Cataldo, president and chief executive officer of Genesis Biopharma. “By utilizing the services of leading consultants, we are able to secure the requisite specialty talent to support our business plan in a cost-effective manner.”

IMPORTANT: Bookmark this link: Check This Link Every Morning for New Spotlight Stocks All of these are date and time stamped so you know what is current today. You can also just go to STOCKGURU.COM and look for the link in the top navigation for “StockGuru Spotlight.”

You can also put the RSS link into your RSS reader9, such as my favorite “Google Reader.”

There are countless programs that make it easy to get RSS feeds on your wireless phone as well. This is foolproof BUT ONLY IF YOU CHECK YOUR RSS FEED REGULARLY! RSS link on the site. We do not yet send out Spotlight Alerts by email, in an attempt to give your email box a break. Spotlights occur several times weekly, and are released ONLY when we see a valid reason. Occasionally, our Spotlights are compensated picks, but an editorial decision is made as to whether the situation qualifies as a market sensitive pick and we ALWAYS include a disclosure prominently if we include a company for which we have been compensated in either cash or shares.

StockGuru is in its Ninth Year!